| Code | 3294D | ||||||||||
| MA number | EU/1/19/1404/002 | ||||||||||
| Product Form: | tbl plg 30x15 mg (fľ.HDPE) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 16.12.2019 |
| Validity: | 16.12.2024 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Rinvoq_Edukacna prirucka pre lekarov.pdf
|
| Dokument: |
Rinvoq_Karta pacienta.pdf
|
| Safety feature | Yes |
| Data update: | 16.03.2021 |
